Interim analysis of a randomized phase II trial comparing continuous lenalidomide and dexamethasone to autologous stem cell transplantation in multiple myeloma patients responsive to lenalidomide and dexamethasone induction Meeting Abstract


Authors: Weltz, J. I.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; Devlin, S. M.; Riedel, E.; Woo, K. M.; Stellman, A.; Chimento, D.; Kewalramani, T.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Hassoun, H.
Abstract Title: Interim analysis of a randomized phase II trial comparing continuous lenalidomide and dexamethasone to autologous stem cell transplantation in multiple myeloma patients responsive to lenalidomide and dexamethasone induction
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349243501043
PROVIDER: wos
DOI: 10.1182/blood.V124.21.3991.3991
Notes: Meeting Abstract: 3991 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1050 Giralt
  2. Hani Hassoun
    329 Hassoun
  3. Heather Jolie Landau
    419 Landau
  4. Nikoletta Lendvai
    106 Lendvai
  5. Alexander Meyer Lesokhin
    363 Lesokhin
  6. David Chung
    240 Chung
  7. Sean McCarthy Devlin
    601 Devlin
  8. Jonathan Ian Weltz
    4 Weltz
  9. Kaitlin Marie Woo
    101 Woo
  10. Carl Ola Landgren
    336 Landgren